FAQ: Jupiter Neurosciences' Nugevia™ Longevity Supplement Launch

What is Nugevia™ and who is behind it?

Nugevia™ is a direct-to-consumer longevity product line launched by Jupiter Neurosciences Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company, leveraging their JOTROL™ resveratrol formulation.

Why did Jupiter Neurosciences launch Nugevia™?

It harmonizes their strategy by developing drugs for CNS disorders and rare diseases while creating a DTC arm to drive revenue and cashflow, reducing dependency on the slower clinical drug development process.

What are the key benefits of Nugevia™ products?

They improve mitochondrial support, mental clarity, and ‘beauty from within,’ backed by antioxidant, anti-inflammatory effects, DNA repair via PARP-1 activation, cardiovascular health, cognitive enhancement, and antibacterial/antiviral properties.

How is Nugevia™ different from other supplements?

It features precision-engineered ‘intelligent stacking’ of synergistic compounds for enhanced cellular resilience, blood-brain barrier delivery, and system-wide optimization, unlike single-ingredient supplements.

What specific products are available under Nugevia™?

The first three formulations target mitochondrial support, mental clarity, and beauty; examples include Nugevia GLO for skin radiance and resilience and Nugevia PWR for mitochondrial health.

When was Nugevia™ launched?

The launch was announced on August 19, 2025, as part of Jupiter Neurosciences’ milestone in solidifying their business approach.

How is Nugevia™ sold and what market does it address?

It is sold via a direct-to-consumer (DTC) model, targeting the booming longevity market valued at $65 billion in 2023 and projected to reach $314 billion by 2030, with a combined mind, beauty, and energy addressable market of $8 trillion.

What scientific backing does Nugevia™ have?

It is powered by JOTROL, a patent-protected resveratrol formulation with over eight years of pharmaceutical development, designed to deliver therapeutically relevant, safe levels with unmatched bioavailability and scientific credibility.